Fiduciary Group LLC Abbott Laboratories Transaction History

Fiduciary Group LLC

$918 Million
Q2 2024

A detailed history of Fiduciary Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fiduciary Group LLC holds 16,424 shares of ABT stock, worth $1.86 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

16,424

Previous 16,692 1.61%

Holding current value

$1.86 Million

Previous $1.9 Million 10.07%

% of portfolio

0.19%

Previous 0.21%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $26,995 - $30,133	-268 Reduced 1.61%	16,424 $1.71 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $35,265 - $38,949	-322 Reduced 1.89%	16,692 $1.9 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $9,830 - $12,033	-109 Reduced 0.64%	17,014 $1.87 Million
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $20,156 - $22,458	-200 Reduced 1.15%	17,123 $1.87 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $7,942 - $9,348	-82 Reduced 0.47%	17,323 $1.75 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $19,372 - $22,802	-200 Reduced 1.15%	17,123 $1.73 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $17,205 - $20,185	-181 Reduced 1.03%	17,405 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $4,160 - $4,817	43 Added 0.25%	17,586 $1.83 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $42,767 - $51,692	419 Added 2.45%	17,543 $1.91 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $1,710 - $2,085	-15 Reduced 0.09%	17,124 $1.81 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $20,217 - $24,755	-175 Reduced 1.01%	17,139 $2.41 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $61,246 - $67,756	-525 Reduced 2.94%	17,314 $2.22 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $29,621 - $34,868	280 Added 1.59%	17,839 $2.17 Million
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $23,182 - $27,312	-213 Reduced 1.2%	17,559 $2.11 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $27,300 - $29,749	-260 Reduced 1.44%	17,772 $2.25 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $4,582 - $5,564	-50 Reduced 0.28%	18,032 $1.96 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $12,012 - $13,372	-153 Reduced 0.84%	18,082 $1.57 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $52,704 - $57,148	-644 Reduced 3.41%	18,235 $1.53 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $64,134 - $74,800	-880 Reduced 4.45%	18,879 $1.59 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $13,575 - $16,412	-205 Reduced 1.03%	19,759 $1.58 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $22,618 - $25,623	-345 Reduced 1.7%	19,964 $1.44 Million
Q3 2018 Oct 18, 2018	SELL	$60.81 - $73.36 $15,506 - $18,706	-255 Reduced 1.24%	20,309 $1.49 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $4,893 - $5,400	-85 Reduced 0.41%	20,564 $1.25 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $16,036 - $18,131	285 Added 1.4%	20,649 $1.24 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $12,078 - $12,930	-225 Reduced 1.09%	20,364 $1.16 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $989,507 - $1.1 Million	20,589	20,589 $1.1 Million

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Account

Fiduciary Group LLC Abbott Laboratories Transaction History